Clinical progress note: Varicella Zoster
- PMID: 40801156
- DOI: 10.1002/jhm.70126
Clinical progress note: Varicella Zoster
Abstract
Varicella Zoster virus (VZV) is the etiologic agent responsible for varicella and herpes zoster (shingles). Nonimmune children and adults acutely infected with VZV typically experience a vesicular and pruritic rash that progresses from the face and trunk and generalizes to the extremities, accompanied by an oral enanthem along with symptoms of fever and malaise. Later, the virus may reactivate from dormancy in the dorsal root ganglia, leading to a stereotypical, unilateral, painful, vesicular rash limited to one or two dermatomes. While either pattern of infection is usually self-limited in healthy children, more severe complications including death may occur among immunocompromised, pregnant, or adult patients. VZV vaccines have greatly reduced morbidity and mortality since their introduction more than 30 years ago. Hospitalists should be prepared to recognize and treat patients with VZV infection, particularly in an era of increasing vaccine hesitancy.
© 2025 The Author(s). Journal of Hospital Medicine published by Wiley Periodicals LLC on behalf of Society of Hospital Medicine.
Similar articles
-
Vaccines for preventing herpes zoster in older adults.Cochrane Database Syst Rev. 2023 Oct 2;10(10):CD008858. doi: 10.1002/14651858.CD008858.pub5. Cochrane Database Syst Rev. 2023. PMID: 37781954 Free PMC article.
-
Breaking the cycle: considerations for a life-course vaccination strategy against varicella-zoster virus.Expert Rev Vaccines. 2025 Dec;24(1):556-569. doi: 10.1080/14760584.2025.2514527. Epub 2025 Jun 19. Expert Rev Vaccines. 2025. PMID: 40511469 Review.
-
Vaccines for preventing herpes zoster in older adults.Cochrane Database Syst Rev. 2016 Mar 3;3(3):CD008858. doi: 10.1002/14651858.CD008858.pub3. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2019 Nov 7;2019(11). doi: 10.1002/14651858.CD008858.pub4. PMID: 26937872 Free PMC article. Updated.
-
Vaccines for preventing herpes zoster in older adults.Cochrane Database Syst Rev. 2012 Oct 17;10:CD008858. doi: 10.1002/14651858.CD008858.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2016 Mar 03;3:CD008858. doi: 10.1002/14651858.CD008858.pub3. PMID: 23076951 Updated.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
References
REFERENCES
-
- Gershon AA, Breuer J, Cohen JI, et al. Varicella zoster virus infection. Nat Rev Dis Primers. 2015;1:15016. doi:10.1038/nrdp.2015.16
-
- de Oliveira Gomes J, Gagliardi AM, Andriolo BN, et al. Vaccines for preventing herpes zoster in older adults. Cochrane Database Syst Rev. 2023;10(10):CD008858. doi:10.1002/14651858.CD008858.pub5
-
- Marin M, Seward JF, Gershon AA. 25 years of varicella vaccination In the United States. J Infect Dis. 2022;226(suppl 4):S375‐S379. doi:10.1093/infdis/jiac251
-
- Shapiro ED, Marin M. The effectiveness of varicella vaccine: 25 years of postlicensure experience In the United States. J Infect Dis. 2022;226(suppl 4):S425‐S430. doi:10.1093/infdis/jiac299
-
- American Academy of Pediatrics, Committee on Infectious Diseases. Varicella‐zoster virus infections. In: Kimberlin DW, Banerjee R, Barnett ED, Lynfield R, Sawyer MH, editors, 2024‐2027 report of the Committee on Infectious Diseases. American Academy of Pediatrics, Red Book; 2024.
LinkOut - more resources
Full Text Sources